These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetic considerations of antidepressant use in the elderly. DeVane CL; Pollock BG J Clin Psychiatry; 1999; 60 Suppl 20():38-44. PubMed ID: 10513858 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic aspects of antidepressant treatment in the elderly. Norman TR Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):329-44. PubMed ID: 8475316 [TBL] [Abstract][Full Text] [Related]
4. Gender differences in depression and antidepressant pharmacokinetics and adverse events. Frackiewicz EJ; Sramek JJ; Cutler NR Ann Pharmacother; 2000 Jan; 34(1):80-8. PubMed ID: 10669189 [TBL] [Abstract][Full Text] [Related]
5. [Current concepts on the subject of properties and use of antidepressants]. Białecka M Pol Merkur Lekarski; 1997 Apr; 2(10):295-7. PubMed ID: 9377672 [TBL] [Abstract][Full Text] [Related]
6. Clinically significant drug interactions with antidepressants in the elderly. Spina E; Scordo MG Drugs Aging; 2002; 19(4):299-320. PubMed ID: 12038880 [TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications. von Moltke LL; Greenblatt DJ; Shader RI Clin Pharmacokinet; 1993 Feb; 24(2):141-60. PubMed ID: 8471078 [TBL] [Abstract][Full Text] [Related]
8. Recent pharmacologic advances in antidepressant therapy for the elderly. Preskorn SH Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477 [TBL] [Abstract][Full Text] [Related]
10. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Dechant KL; Clissold SP Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852 [TBL] [Abstract][Full Text] [Related]
11. A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents. Renaud J; Axelson D; Birmaher B Drug Saf; 1999 Jan; 20(1):59-75. PubMed ID: 9935277 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant pharmacodynamics, pharmacokinetics, and drug interactions. Ereshefsky L Geriatrics; 1998 Dec; 53 Suppl 4():S22-33. PubMed ID: 9861902 [No Abstract] [Full Text] [Related]
13. Psychopharmacologic treatment of depression in the medically ill. Beliles K; Stoudemire A Psychosomatics; 1998; 39(3):S2-19. PubMed ID: 9664784 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant drugs in the elderly--role of the cytochrome P450 2D6. Vandel P World J Biol Psychiatry; 2003 Apr; 4(2):74-80. PubMed ID: 12692778 [TBL] [Abstract][Full Text] [Related]
15. Depression in the elderly: pharmacologic considerations in treatment. Veith RC J Am Geriatr Soc; 1982 Sep; 30(9):581-6. PubMed ID: 6125536 [TBL] [Abstract][Full Text] [Related]
16. Risk-benefit analysis of antidepressant drug treatment in the elderly. Alamo C; López-Muñoz F; García-García P; García-Ramos S Psychogeriatrics; 2014 Dec; 14(4):261-8. PubMed ID: 25495088 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic considerations in treating depression in the elderly. Dunner DL J Clin Psychiatry; 1994 Dec; 55 Suppl():48-58; discussion 59-60. PubMed ID: 7814358 [TBL] [Abstract][Full Text] [Related]
18. Pindolol augmentation of antidepressants: a review and rationale. Olver JS; Cryan JF; Burrows GD; Norman TR Aust N Z J Psychiatry; 2000 Feb; 34(1):71-9. PubMed ID: 11185947 [TBL] [Abstract][Full Text] [Related]
19. Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression. Scates AC; Doraiswamy PM Ann Pharmacother; 2000 Nov; 34(11):1302-12. PubMed ID: 11098346 [TBL] [Abstract][Full Text] [Related]